A PHASE 2, DOUBLE-MASKED, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, DOSE-RESPONSE PARALLEL-GROUP STUDY COMPARING THE SAFETY AND OCULAR HYPOTENSIVE EFFICACY OF NETARSUDIL (AR-13324) TO LATANOPROST IN PATIENTS WITH ELEVATED INTRAOCULAR PRESSURE: